Zions Bancorporation N.A. grew its holdings in Boston Scientific Co. (NYSE:BSX – Free Report) by 17.8% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,600 shares of the medical equipment provider’s stock after purchasing an additional 847 shares during the quarter. […]
Zions Bancorporation N.A. boosted its holdings in shares of Boston Scientific Co. (NYSE:BSX – Free Report) by 17.8% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 5,600 shares of the medical equipment provider’s stock after buying an additional 847 shares during the […]
Boston Scientific (NYSE:BSX – Get Free Report) had its price target raised by investment analysts at Royal Bank of Canada from $67.00 to $70.00 in a research report issued on Thursday, Benzinga reports. The firm currently has an “outperform” rating on the medical equipment provider’s stock. Royal Bank of Canada’s price objective indicates a potential […]
Boston Scientific (NYSE:BSX – Get Free Report) had its price objective boosted by investment analysts at Royal Bank of Canada from $67.00 to $70.00 in a note issued to investors on Thursday, Benzinga reports. The brokerage currently has an “outperform” rating on the medical equipment provider’s stock. Royal Bank of Canada’s target price points to […]